시장보고서

상품코드

1780290

세계의 기증자 혈액 성분 시장 : 시장 규모 및 예측, 지역 점유율, 동향, 성장 기회 분석 보고서 - 혈액 성분별, 적응증별, 용도별, 연령대별, 최종 사용자별, 지역별(2021-2031년)

Donor Blood Components Market Size and Forecast 2021-2031, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: Blood Component, Indication, Application, Age Group, End User, and Geography

발행일: 2025년 07월 | 리서치사:

The Insight Partners | 페이지 정보: 영문 342 Pages | 배송안내 : 즉시배송

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

당사의 최신 조사 보고서 '세계의 기증자 혈액 성분 시장 : 예측 및 분석-혈액 성분별, 적응증별, 용도별, 연령층별, 지역별(-2031년)'에 의하면, 시장은 2024년의 100억 8,000만 달러로 평가되었고, 2031년에는 146억 4,000만 달러에 도달할 전망이며, 5.7%를 기록할 것으로 예측되고, 암 및 면역억제성 질환 유병률 상승, 기증자 의식 증가가 기증자 혈액 성분 시장 규모의 확대에 기여하고 있습니다. 그러나 자발적인 헌혈이 안정되지 않는 것이 기증자 혈액 성분 시장의 성장을 방해하고 있습니다. 게다가 혈장 유래 치료에 대한 수요의 고조는 향후 수년간 새로운 기증자 혈액 성분 시장 동향을 가져올 것으로 예상됩니다.

기증자 혈액 성분 시장은 수술, 외상, 암 치료, 만성 질환에서 안전한 수혈의 필요성이 증가함에 따라 헬스케어 산업의 두드러진 부문 중 하나입니다. 기증자 혈액 성분에는 적혈구(RBC), 혈장, 혈소판, 동결 침전물이 포함됩니다. 기증자 혈액 성분 시장의 성장은, 세계 의식의 고조, 인구의 고령화, 수집 및 보존 기술의 진보에 의해서 추진되고 있습니다. 그러나 특정 지역의 낮은 자발적 헌혈률, 규제상의 문제, 물류상의 제약과 같은 문제는 여전히 남아 있습니다. 아페레시스나 병원체 감소 시스템 등의 신기술은 제품의 안전성과 효율을 향상시키고 있습니다. 또한 정기적이고 자발적인 헌혈을 늘리기 위한 정부와 NGO의 노력이 헌혈자 수를 늘리고 있습니다. 이 시장은 특히 진화하는 헬스케어 시스템에서 큰 가능성을 가지고 있습니다.

기증자 혈액 성분 시장 분석

신흥 시장 수요가 미래 시장 기회를 가져옵니다.

신흥 경제권, 특히 동남아시아, 라틴아메리카, 아프리카의 일부 지역은 공여자 혈액 성분 시장에 큰 성장 기회를 제공합니다. 이들 경제권의 헬스케어 인프라가 성장함에 따라 헌혈 시설에 대한 투자가 전략적 필수사항으로 떠오르고 있습니다. 아르헨티나, 브라질, 멕시코에서는 자발적 헌혈 프로그램이 큰 지지를 받고 있습니다. : 라틴 아메리카에서는 2023년에는 2020년 대비 15.5% 증가한 920만 단위 이상의 헌혈이 이루어졌으며, 그 중 56.8%는 모바일 드라이브 및 온라인 캠페인을 통한 자발적인 것이었습니다. 이 성장은, 각국의 혈액 시스템에 영향을 준 계발 캠페인이나 관민 제휴의 협조를 나타내고 있습니다. 마찬가지로 예를 들면 인도네시아에서는 Asian Agri와 같은 기업 헌혈자들이 지역 헌혈 주간을 시작하여 지방 주에서 수백 단위를 모았습니다. 2024년 6월에는 414명의 기증자가 참여해 3개 주에서 287단위가 모여 재고와 의식 향상에 기여했습니다. 이러한 민간 부문의 협력은 지역 사회의 신뢰 및 기부자의 참여를 높입니다.

WHO에 따르면 개발도상국에서는 혈액제제 수요가 매년 5% 증가할 것으로 예측되고 있습니다. 이러한 수요에 대응하기 위해, 인도네시아의 새로운 혈장분획 공장이나 아프리카에서의 이동 채혈 증가 등, 각국은 인프라의 근대화에 힘을 쓰고 있습니다. 어페레시스 기기, NAT 검사, 자동화 처리와 같은 형태로 기술 이용이 진행되어 안전성과 사회적 신용이 높아지고 있습니다.

증대하는 의료 수요, 자발적 헌혈 증가, 디지털 지원 활동, 규제 개혁이 융합함으로써 신흥 시장은 기증자 혈액 서비스의 성장에 적합합니다. 이러한 시스템의 개발은 임상 요구의 증가에 대응할 뿐만 아니라 세계 기증자 혈액 성분 시장의 장기적인 지속 가능성을 촉진합니다.

기증자 혈액 성분 시장의 세분화 분석

기증자 혈액 성분 시장 분석에 기여한 주요 부문은 혈액 성분, 적응증, 용도, 연령대, 성별, 최종 사용자입니다.

혈액 성분별로 기증자 혈액 성분 시장은 적혈구, 백혈구, 혈소판, 혈장 등으로 구분됩니다. 2024년에는 적혈구 부문이 시장에서 가장 큰 점유율을 차지했습니다.

적응증별로 기증자 혈액 성분 시장은 면역 억제 및 종양으로 이분됩니다. 2024년에는 면역억제 분야가 시장을 독점했습니다.

용도별로 기증자 혈액 성분 시장은 빈혈 관리, 혈소판 감소증 치료, 응고 장애 보정, 화학요법 중 지지요법, 수술, 기타로 구분됩니다. 빈혈 관리 분야는 2024년 시장에서 가장 큰 점유율을 차지했습니다.

연령대별로 기증자 혈액 성분 시장은 성인과 소아로 이분됩니다. 2024년에는 성인 부문이 시장을 독점했습니다.

최종 사용자별로 기증자 혈액 성분 시장은 병원, 종양 센터, 이식 센터, 외래수술센터(ASC) 및 기타로 분류됩니다. 2024년 시장은 병원 부문이 가장 큰 점유율을 차지했습니다.

기증자 혈액 성분 시장 경쟁 구도 및 주요 발전

Roswell Park Comprehensive Cancer Center, Policinico of Milan, Vitalant, MD Anderson Cancer Center, The Johns Hopkins Hospital, The Royal Marsden, Gustave Roussy, Peter MacCallum Cancer Centre, Tata Memorial Hospital, Memorial Sloan Kettering Cancer Center 등이 기증자 혈액 성분 시장에서 사업을 전개하고 있는 주요 기업입니다.

세계보건기구(WHO), 미국형성외과학회, 보건자원서비스청, 미국암협회, 백혈병림프종협회, 캐나다 보건부, 국제암연구기관(IARC), 연방통계국(Destatis), 맥밀란암 지원 데이터, National Health Commission(NHC), Indian Council of Medical Research-National Research(ICMR-NCDIR), Australian Institute of Health and Welfare, Australian Red Cross Lifeblood, GLOBOCAN 등은 기증자 혈액 성분 시장 보고서를 작성할 때 참조한 1차 및 2차 조사 정보입니다.

기증자 혈액 성분 시장-주요 시장 역학
시장 성장 촉진요인
- 암 및 면역억제성 질환의 유병률 상승
- 기증자에 대한 의식 증가
시장 성장 억제요인
- 일관성이 없는 자발적 헌혈
시장 기회
- 신흥 시장 수요
향후의 동향
- 혈장 유래 치료에 대한 수요 증가
성장 촉진요인 및 억제요인의 영향

제6장 기증자 혈액 성분 시장 : 세계 시장 분석

기증자 혈액 성분 시장의 수익(2021-2031년)
기증자 혈액 성분 시장 예측 분석

제7장 기증자 혈액 성분 시장 분석 : 혈액 성분별

적혈구
백혈구
혈소판
혈장
기타

제8장 기증자 혈액 성분 시장 분석 : 적응증별

면역억제
종양

제9장 기증자 혈액 성분 시장 분석 : 용도별

빈혈 관리
혈소판 감소 치료
응고장애 보정
화학요법 중의 지지요법
수술 수술
기타

제10장 기증자 혈액 성분 시장 분석 : 연령층별

성인
소아

제11장 기증자 혈액 성분 시장 분석 : 최종 사용자별

병원
종양센터
이식 센터
외래수술센터(ASC)
기타

제12장 기증자 혈액 성분 시장 : 지역별 분석

북미
- 미국
- 캐나다
- 멕시코
유럽
- 독일
- 영국
- 프랑스
- 스페인
- 이탈리아
- 유럽의 기타 국가
아시아태평양
- 중국
- 일본
- 인도
- 호주
- 한국
- 아시아태평양의 기타 국가
중동 및 아프리카
- 사우디아라비아
- 남아프리카
- 아랍에미리트(UAE)
- 중동 및 아프리카의 다른 국가
중남미
- 브라질
- 아르헨티나
- 중남미의 기타 국가

제13장 업계 정세

기증자 혈액 성분 시장의 성장 전략
유기적 성장 전략
무기적 성장 전략

제14장 기업 프로파일

Roswell Park Comprehensive Cancer Center
Policlinico of Milan
Vitalant
MD Anderson Cancer Center.
The Johns Hopkins Hospital
The Royal Marsden
Gustave Roussy
Peter MacCallum Cancer Centre
Tata Memorial Hospital
Memorial Sloan Kettering Cancer Center

제15장 부록

AJY 25.08.08

According to our new research study on "Donor Blood Component Market Forecast to 2031 -Global Analysis - by Blood Component, Indication, Application, Age Group, and Geography," the market is anticipated to grow from US$ 10.08 billion in 2024 and is projected to reach US$ 14.64 billion by 2031; it is expected to register a CAGR of 5.7% during 2025-2031. Rising prevalence of cancer and immunosuppressive diseases, and increasing donor awareness are contributing to the growing donor blood component market size. However, the inconsistent voluntary donations hamper the donor blood component market growth. Further, rising demand for plasma-derived therapies are expected to bring in new donor blood component market trends in the coming years.

The donor blood components market is one of the prominent segments of the healthcare industry, driven by the increasing need for safe transfusions during surgery, trauma, cancer treatment, and chronic disease. Donor blood components include red blood cells (RBCs), plasma, platelets, and cryoprecipitate. The donor blood components market growth is being propelled by rising global awareness, aging populations, and growing advancements in collection and storage technologies. However, issues such as low rates of voluntary donations in certain regions, regulatory issues, and logistical limitations remain. New technologies such as apheresis and pathogen reduction systems are improving product safety and efficiency. Furthermore, government and NGO initiatives to increase regular, voluntary blood donation are increasing the donor base. The market has great potential, particularly in evolving healthcare systems.

Donor Blood Component Market Analysis

Emerging Market Demand to Provide Market Opportunities in Future

Emerging economies, particularly in Southeast Asia, Latin America, and some regions in Africa, offer a strong growth opportunity for the donor blood component market. As healthcare infrastructure in these economies grows, investment in blood donation facilities is emerging as a strategic imperative. In Argentina, Brazil, and Mexico, voluntary donations voluntary donation programs have gained significant traction: Latin America received more than 9.2 million units in 2023, a 15.5% increase over 2020, with 56.8% of donations voluntary due to mobile drives and online campaigns. This growth represents the collaborative coordination of awareness campaigns and public-private alliances that have had on national blood systems. Similarly, in Indonesia, for instance, corporate donors such as Asian Agri initiated regional Blood Donation Weeks, accumulating hundreds of units from rural provinces. In June 2024, they engaged 414 donors and collected 287 units from three provinces, contributing to inventory and awareness. These private-sector cooperation enhances community trust and donor participation.

According to the WHO, the demand for blood products is projected to increase 5% each year in developing nations. To respond to the demand, the nations are focusing on the modernization of infrastructure, such as Indonesia's new plasma-fractionation factory and increased mobile blood collections in Africa. Technological utilization in the form of apheresis equipment, NAT testing, and automation processing is enhancing safety and public trust.

The convergence of growing medical demand, increasing voluntary donation, digital outreach, and regulatory reforms positions emerging markets for growth in donor blood services. Developments in these systems not only meet increasing clinical need but also catalyze long-term sustainability in the global donor blood component market.

Donor Blood Component Market Report Segmentation Analysis

Key segments that contributed to the derivation of the donor blood component market analysis are Blood Component, Indication, application, age group, gender, and end user.

Based on blood component, the donor blood components market is segmented into red blood cells, white blood cells, platelets, plasma, and others. The red blood cells segment held the largest share of the market in 2024.

By indication, the donor blood components market is bifurcated into immunosuppression and oncology. The immunosuppression segment dominated the market in 2024.

In terms of application, the donor blood components market is segmented into anemia management, thrombocytopenia treatment, coagulopathy correction, supportive care during chemotherapy, surgery, and others. The anemia management segment held the largest share of the market in 2024.

By age group, the donor blood components market is bifurcated into adult and child. The adult segment dominated the market in 2024.

As per end user, the donor blood components market is categorized into hospitals, oncology centers, transplant centers, ambulatory surgical centers, and others. The hospitals segment dominated the market in 2024.

Donor Blood Component Market: Competitive Landscape and Key Developments

Roswell Park Comprehensive Cancer Center, Policlinico of Milan, Vitalant, MD Anderson Cancer Center, The Johns Hopkins Hospital, The Royal Marsden, Gustave Roussy, Peter MacCallum Cancer Centre, Tata Memorial Hospital, Memorial Sloan Kettering Cancer Center are among the key companies operating in the donor blood component market.

The World Health Organization (WHO), the American Society of Plastic Surgeons, Health Resources and Services Administration, American Cancer Society, The Leukemia & Lymphoma Society, Health Canada, International Agency for Research on Cancer (IARC), Federal Statistical Office (Destatis), Macmillan Cancer Support data, National Health Commission (NHC), Indian Council of Medical Research-National Centre for Disease Informatics and Research (ICMR-NCDIR), Australian Institute of Health and Welfare, Australian Red Cross Lifeblood, GLOBOCAN are among the primary and secondary sources referred to while preparing the donor blood components market report.

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Analyst Market Outlook

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
3.3 Assumptions and Limitations

4. Donor Blood Component Market Landscape

4.1 Overview
4.2 PEST Analysis
4.3 Average Selling Price Per Unit (US$) of Blood Components, 2024
4.4 Global Disease Prevalence of 5 Key Diseases, 2024

5. Donor Blood Component Market - Key Market Dynamics

5.1 Donor Blood Component Market - Key Market Dynamics
5.2 Market Drivers
- 5.2.1 Rising Prevalence of Cancer and Immunosuppressive Diseases
- 5.2.2 Increasing Donor Awareness
5.3 Market Restraints
- 5.3.1 Inconsistent Voluntary Donations
5.4 Market Opportunities
- 5.4.1 Emerging Market Demand
5.5 Future Trends
- 5.5.1 Rising Demand for Plasma-Derived Therapies
5.6 Impact of Drivers and Restraints:

6. Donor Blood Component Market - Global Market Analysis

6.1 Donor Blood Component Market Revenue (US$ Million), 2021-2031
6.2 Donor Blood Component Market Forecast Analysis

7. Donor Blood Component Market Analysis - by Blood Component

7.1 Red Blood Cells
- 7.1.1 Overview
- 7.1.2 Red Blood Cells: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
7.2 White blood cells
- 7.2.1 Overview
- 7.2.2 White blood cells: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
7.3 Platelets
- 7.3.1 Overview
- 7.3.2 Platelets: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
7.4 Plasma
- 7.4.1 Overview
- 7.4.2 Plasma: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
7.5 Others
- 7.5.1 Overview
- 7.5.2 Others: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)

8. Donor Blood Component Market Analysis - by Indication

8.1 Immunosuppression
- 8.1.1 Overview
- 8.1.2 Immunosuppression: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
8.2 Oncology
- 8.2.1 Overview
- 8.2.2 Oncology: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)

9. Donor Blood Component Market Analysis - by Application

9.1 Anemia management
- 9.1.1 Overview
- 9.1.2 Anemia management: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
9.2 Thrombocytopenia treatment
- 9.2.1 Overview
- 9.2.2 Thrombocytopenia treatment: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
9.3 Coagulopathy Correction
- 9.3.1 Overview
- 9.3.2 Coagulopathy Correction: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
9.4 Supportive care during chemotherapy
- 9.4.1 Overview
- 9.4.2 Supportive care during chemotherapy: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
9.5 Surgery
- 9.5.1 Overview
- 9.5.2 Surgery: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
9.6 Others
- 9.6.1 Overview
- 9.6.2 Others: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)

10. Donor Blood Component Market Analysis - by Age Group

10.1 Adult
- 10.1.1 Overview
- 10.1.2 Adult: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
10.2 Child
- 10.2.1 Overview
- 10.2.2 Child: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)

11. Donor Blood Component Market Analysis - by End User

11.1 Hospitals
- 11.1.1 Overview
- 11.1.2 Hospitals: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
11.2 Oncology centers
- 11.2.1 Overview
- 11.2.2 Oncology centers: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
11.3 Transplant centers
- 11.3.1 Overview
- 11.3.2 Transplant centers: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
11.4 Ambulatory surgical centers
- 11.4.1 Overview
- 11.4.2 Ambulatory surgical centers: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
11.5 Others
- 11.5.1 Overview
- 11.5.2 Others: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)

12. Donor Blood Component Market - Geographical Analysis

12.1 North America
- 12.1.1 North America Donor Blood Component Market Overview
- 12.1.2 North America: Donor Blood Component Market - Revenue, 2021-2031 (US$ Million)
  - 12.1.2.1 North America: Donor Blood Component Market - Revenue and Forecast Analysis - by Blood Component
  - 12.1.2.2 North America: Donor Blood Component Market - Volume and Forecast Analysis - by Blood Component
  - 12.1.2.3 North America: Donor Blood Component Market - Revenue and Forecast Analysis - by Indication
    - 12.1.2.3.1 North America: Donor Blood Component Market - Revenue and Forecast Analysis - by Immunosuppression
    - 12.1.2.3.2 North America: Donor Blood Component Market - Revenue and Forecast Analysis - by Oncology
  - 12.1.2.4 North America: Donor Blood Component Market - Revenue and Forecast Analysis - by Application
  - 12.1.2.5 North America: Donor Blood Component Market - Revenue and Forecast Analysis - by Age Group
  - 12.1.2.6 North America: Donor Blood Component Market - Revenue and Forecast Analysis - by End User
- 12.1.3 North America: Donor Blood Component Market - Revenue and Forecast Analysis - by Country
  - 12.1.3.1 United States: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 12.1.3.1.1 United States: Donor Blood Component Market Breakdown, by Blood Component
    - 12.1.3.1.2 United States: Donor Blood Component Market Breakdown, by Blood Component
    - 12.1.3.1.3 United States: Donor Blood Component Market Breakdown, by Indication
      - 12.1.3.1.3.1 United States: Donor Blood Component Market Breakdown, by Immunosuppression
      - 12.1.3.1.3.2 United States: Donor Blood Component Market Breakdown, by Oncology
    - 12.1.3.1.4 United States: Donor Blood Component Market Breakdown, by Application
    - 12.1.3.1.5 United States: Donor Blood Component Market Breakdown, by Age Group
    - 12.1.3.1.6 United States: Donor Blood Component Market Breakdown, by End User
  - 12.1.3.2 Canada: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 12.1.3.2.1 Canada: Donor Blood Component Market Breakdown, by Blood Component
    - 12.1.3.2.2 Canada: Donor Blood Component Market Breakdown, by Blood Component
    - 12.1.3.2.3 Canada: Donor Blood Component Market Breakdown, by Indication
      - 12.1.3.2.3.1 Canada: Donor Blood Component Market Breakdown,
      - 12.1.3.2.3.2 Canada: Donor Blood Component Market Breakdown, by Oncology
    - 12.1.3.2.4 Canada: Donor Blood Component Market Breakdown, by Application
    - 12.1.3.2.5 Canada: Donor Blood Component Market Breakdown, by Age Group
    - 12.1.3.2.6 Canada: Donor Blood Component Market Breakdown, by End User
  - 12.1.3.3 Mexico: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 12.1.3.3.1 Mexico: Donor Blood Component Market Breakdown, by Blood Component
    - 12.1.3.3.2 Mexico: Donor Blood Component Market Breakdown, by Blood Component
    - 12.1.3.3.3 Mexico: Donor Blood Component Market Breakdown, by Indication
      - 12.1.3.3.3.1 Mexico: Donor Blood Component Market Breakdown, by Immunosuppression
      - 12.1.3.3.3.2 Mexico: Donor Blood Component Market Breakdown, by Oncology
    - 12.1.3.3.4 Mexico: Donor Blood Component Market Breakdown, by Application
    - 12.1.3.3.5 Mexico: Donor Blood Component Market Breakdown, by Age Group
    - 12.1.3.3.6 Mexico: Donor Blood Component Market Breakdown, by End User
12.2 Europe
- 12.2.1 Europe Donor Blood Component Market Overview
- 12.2.2 Europe: Donor Blood Component Market - Revenue, 2021-2031 (US$ Million)
  - 12.2.2.1 Europe: Donor Blood Component Market - Revenue and Forecast Analysis - by Blood Component
  - 12.2.2.2 Europe: Donor Blood Component Market - Volume and Forecast Analysis - by Blood Component
  - 12.2.2.3 Europe: Donor Blood Component Market - Revenue and Forecast Analysis - by Indication
    - 12.2.2.3.1 Europe: Donor Blood Component Market - Revenue and Forecast Analysis - by Immunosuppression
    - 12.2.2.3.2 Europe: Donor Blood Component Market - Revenue and Forecast Analysis - by Oncology
  - 12.2.2.4 Europe: Donor Blood Component Market - Revenue and Forecast Analysis - by Application
  - 12.2.2.5 Europe: Donor Blood Component Market - Revenue and Forecast Analysis - by Age Group
  - 12.2.2.6 Europe: Donor Blood Component Market - Revenue and Forecast Analysis - by End User
- 12.2.3 Europe: Donor Blood Component Market - Revenue and Forecast Analysis - by Country
  - 12.2.3.1 Germany: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 12.2.3.1.1 Germany: Donor Blood Component Market Breakdown, by Blood Component
    - 12.2.3.1.2 Germany: Donor Blood Component Market Breakdown, by Blood Component
    - 12.2.3.1.3 Germany: Donor Blood Component Market Breakdown, by Indication
      - 12.2.3.1.3.1 Germany: Donor Blood Component Market Breakdown, by Immunosuppression
      - 12.2.3.1.3.2 Germany: Donor Blood Component Market Breakdown, by Oncology
    - 12.2.3.1.4 Germany: Donor Blood Component Market Breakdown, by Application
    - 12.2.3.1.5 Germany: Donor Blood Component Market Breakdown, by Age Group
    - 12.2.3.1.6 Germany: Donor Blood Component Market Breakdown, by End User
  - 12.2.3.2 United Kingdom: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 12.2.3.2.1 United Kingdom: Donor Blood Component Market Breakdown, by Blood Component
    - 12.2.3.2.2 United Kingdom: Donor Blood Component Market Breakdown, by Blood Component
    - 12.2.3.2.3 United Kingdom: Donor Blood Component Market Breakdown, by Indication
      - 12.2.3.2.3.1 United Kingdom: Donor Blood Component Market Breakdown, by Immunosuppression
      - 12.2.3.2.3.2 United Kingdom: Donor Blood Component Market Breakdown, by Oncology
    - 12.2.3.2.4 United Kingdom: Donor Blood Component Market Breakdown, by Application
    - 12.2.3.2.5 United Kingdom: Donor Blood Component Market Breakdown, by Age Group
    - 12.2.3.2.6 United Kingdom: Donor Blood Component Market Breakdown, by End User
  - 12.2.3.3 France: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 12.2.3.3.1 France: Donor Blood Component Market Breakdown, by Blood Component
    - 12.2.3.3.2 France: Donor Blood Component Market Breakdown, by Blood Component
    - 12.2.3.3.3 France: Donor Blood Component Market Breakdown, by Indication
      - 12.2.3.3.3.1 France: Donor Blood Component Market Breakdown, by Immunosuppression
      - 12.2.3.3.3.2 France: Donor Blood Component Market Breakdown, by Oncology
    - 12.2.3.3.4 France: Donor Blood Component Market Breakdown, by Application
    - 12.2.3.3.5 France: Donor Blood Component Market Breakdown, by Age Group
    - 12.2.3.3.6 France: Donor Blood Component Market Breakdown, by End User
  - 12.2.3.4 Spain: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 12.2.3.4.1 Spain: Donor Blood Component Market Breakdown, by Blood Component
    - 12.2.3.4.2 Spain: Donor Blood Component Market Breakdown, by Blood Component
    - 12.2.3.4.3 Spain: Donor Blood Component Market Breakdown, by Indication
      - 12.2.3.4.3.1 Spain: Donor Blood Component Market Breakdown, by Immunosuppression
      - 12.2.3.4.3.2 Spain: Donor Blood Component Market Breakdown, by Oncology
    - 12.2.3.4.4 Spain: Donor Blood Component Market Breakdown, by Application
    - 12.2.3.4.5 Spain: Donor Blood Component Market Breakdown, by Age Group
    - 12.2.3.4.6 Spain: Donor Blood Component Market Breakdown, by End User
  - 12.2.3.5 Italy: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 12.2.3.5.1 Italy: Donor Blood Component Market Breakdown, by Blood Component
    - 12.2.3.5.2 Italy: Donor Blood Component Market Breakdown, by Blood Component
    - 12.2.3.5.3 Italy: Donor Blood Component Market Breakdown, by Indication
      - 12.2.3.5.3.1 Italy: Donor Blood Component Market Breakdown, by Immunosuppression
      - 12.2.3.5.3.2 Italy: Donor Blood Component Market Breakdown, by Oncology
    - 12.2.3.5.4 Italy: Donor Blood Component Market Breakdown, by Application
    - 12.2.3.5.5 Italy: Donor Blood Component Market Breakdown, by Age Group
    - 12.2.3.5.6 Italy: Donor Blood Component Market Breakdown, by End User
  - 12.2.3.6 Rest of Europe: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 12.2.3.6.1 Rest of Europe: Donor Blood Component Market Breakdown, by Blood Component
    - 12.2.3.6.2 Rest of Europe: Donor Blood Component Market Breakdown, by Blood Component
    - 12.2.3.6.3 Rest of Europe: Donor Blood Component Market Breakdown, by Indication
      - 12.2.3.6.3.1 Rest of Europe: Donor Blood Component Market Breakdown, by Immunosuppression
      - 12.2.3.6.3.2 Rest of Europe: Donor Blood Component Market Breakdown, by Oncology
    - 12.2.3.6.4 Rest of Europe: Donor Blood Component Market Breakdown, by Application
    - 12.2.3.6.5 Rest of Europe: Donor Blood Component Market Breakdown, by Age Group
    - 12.2.3.6.6 Rest of Europe: Donor Blood Component Market Breakdown, by End User
12.3 Asia Pacific
- 12.3.1 Asia Pacific Donor Blood Component Market Overview
- 12.3.2 Asia Pacific: Donor Blood Component Market - Revenue, 2021-2031 (US$ Million)
  - 12.3.2.1 Asia Pacific: Donor Blood Component Market - Revenue and Forecast Analysis - by Blood Component
  - 12.3.2.2 Asia Pacific: Donor Blood Component Market - Volume and Forecast Analysis - by Blood Component
  - 12.3.2.3 Asia Pacific: Donor Blood Component Market - Revenue and Forecast Analysis - by Indication
    - 12.3.2.3.1 Asia Pacific: Donor Blood Component Market - Revenue and Forecast Analysis - by Immunosuppression
    - 12.3.2.3.2 Asia Pacific: Donor Blood Component Market - Revenue and Forecast Analysis - by Oncology
  - 12.3.2.4 Asia Pacific: Donor Blood Component Market - Revenue and Forecast Analysis - by Application
  - 12.3.2.5 Asia Pacific: Donor Blood Component Market - Revenue and Forecast Analysis - by Age Group
  - 12.3.2.6 Asia Pacific: Donor Blood Component Market - Revenue and Forecast Analysis - by End User
- 12.3.3 Asia Pacific: Donor Blood Component Market - Revenue and Forecast Analysis - by Country
  - 12.3.3.1 China: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 12.3.3.1.1 China: Donor Blood Component Market Breakdown, by Blood Component
    - 12.3.3.1.2 China: Donor Blood Component Market Breakdown, by Blood Component
    - 12.3.3.1.3 China: Donor Blood Component Market Breakdown, by Indication
      - 12.3.3.1.3.1 China: Donor Blood Component Market Breakdown, by Immunosuppression
      - 12.3.3.1.3.2 China: Donor Blood Component Market Breakdown, by Oncology
    - 12.3.3.1.4 China: Donor Blood Component Market Breakdown, by Application
    - 12.3.3.1.5 China: Donor Blood Component Market Breakdown, by Age Group
    - 12.3.3.1.6 China: Donor Blood Component Market Breakdown, by End User
  - 12.3.3.2 Japan: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 12.3.3.2.1 Japan: Donor Blood Component Market Breakdown, by Blood Component
    - 12.3.3.2.2 Japan: Donor Blood Component Market Breakdown, by Blood Component
    - 12.3.3.2.3 Japan: Donor Blood Component Market Breakdown, by Indication
      - 12.3.3.2.3.1 Japan: Donor Blood Component Market Breakdown, by Immunosuppression
      - 12.3.3.2.3.2 Japan: Donor Blood Component Market Breakdown, by Oncology
    - 12.3.3.2.4 Japan: Donor Blood Component Market Breakdown, by Application
    - 12.3.3.2.5 Japan: Donor Blood Component Market Breakdown, by Age Group
    - 12.3.3.2.6 Japan: Donor Blood Component Market Breakdown, by End User
  - 12.3.3.3 India: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 12.3.3.3.1 India: Donor Blood Component Market Breakdown, by Blood Component
    - 12.3.3.3.2 India: Donor Blood Component Market Breakdown, by Blood Component
    - 12.3.3.3.3 India: Donor Blood Component Market Breakdown, by Indication
      - 12.3.3.3.3.1 India: Donor Blood Component Market Breakdown, by Immunosuppression
      - 12.3.3.3.3.2 India: Donor Blood Component Market Breakdown, by Oncology
    - 12.3.3.3.4 India: Donor Blood Component Market Breakdown, by Application
    - 12.3.3.3.5 India: Donor Blood Component Market Breakdown, by Age Group
    - 12.3.3.3.6 India: Donor Blood Component Market Breakdown, by End User
  - 12.3.3.4 Australia: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 12.3.3.4.1 Australia: Donor Blood Component Market Breakdown, by Blood Component
    - 12.3.3.4.2 Australia: Donor Blood Component Market Breakdown, by Blood Component
    - 12.3.3.4.3 Australia: Donor Blood Component Market Breakdown, by Indication
      - 12.3.3.4.3.1 Australia: Donor Blood Component Market Breakdown, by Immunosuppression
      - 12.3.3.4.3.2 Australia: Donor Blood Component Market Breakdown, by Oncology
    - 12.3.3.4.4 Australia: Donor Blood Component Market Breakdown, by Application
    - 12.3.3.4.5 Australia: Donor Blood Component Market Breakdown, by Age Group
    - 12.3.3.4.6 Australia: Donor Blood Component Market Breakdown, by End User
  - 12.3.3.5 South Korea: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 12.3.3.5.1 South Korea: Donor Blood Component Market Breakdown, by Blood Component
    - 12.3.3.5.2 South Korea: Donor Blood Component Market Breakdown, by Blood Component
    - 12.3.3.5.3 South Korea: Donor Blood Component Market Breakdown, by Indication
      - 12.3.3.5.3.1 South Korea: Donor Blood Component Market Breakdown, by Immunosuppression
      - 12.3.3.5.3.2 South Korea: Donor Blood Component Market Breakdown, by Oncology
    - 12.3.3.5.4 South Korea: Donor Blood Component Market Breakdown, by Application
    - 12.3.3.5.5 South Korea: Donor Blood Component Market Breakdown, by Age Group
    - 12.3.3.5.6 South Korea: Donor Blood Component Market Breakdown, by End User
  - 12.3.3.6 Rest of APAC: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 12.3.3.6.1 Rest of APAC: Donor Blood Component Market Breakdown, by Blood Component
    - 12.3.3.6.2 Rest of APAC: Donor Blood Component Market Breakdown, by Blood Component
    - 12.3.3.6.3 Rest of APAC: Donor Blood Component Market Breakdown, by Indication
      - 12.3.3.6.3.1 Rest of APAC: Donor Blood Component Market Breakdown, by Immunosuppression
      - 12.3.3.6.3.2 Rest of APAC: Donor Blood Component Market Breakdown, by Oncology
    - 12.3.3.6.4 Rest of APAC: Donor Blood Component Market Breakdown, by Application
    - 12.3.3.6.5 Rest of APAC: Donor Blood Component Market Breakdown, by Age Group
    - 12.3.3.6.6 Rest of APAC: Donor Blood Component Market Breakdown, by End User
12.4 Middle East and Africa
- 12.4.1 Middle East and Africa Donor Blood Component Market Overview
- 12.4.2 Middle East and Africa: Donor Blood Component Market - Revenue, 2021-2031 (US$ Million)
  - 12.4.2.1 Middle East and Africa: Donor Blood Component Market - Revenue and Forecast Analysis - by Blood Component
  - 12.4.2.2 Middle East and Africa: Donor Blood Component Market - Volume and Forecast Analysis - by Blood Component
  - 12.4.2.3 Middle East and Africa: Donor Blood Component Market - Revenue and Forecast Analysis - by Indication
    - 12.4.2.3.1 Middle East and Africa: Donor Blood Component Market - Revenue and Forecast Analysis - by Immunosuppression
    - 12.4.2.3.2 Middle East and Africa: Donor Blood Component Market - Revenue and Forecast Analysis - by Oncology
  - 12.4.2.4 Middle East and Africa: Donor Blood Component Market - Revenue and Forecast Analysis - by Application
  - 12.4.2.5 Middle East and Africa: Donor Blood Component Market - Revenue and Forecast Analysis - by Age Group
  - 12.4.2.6 Middle East and Africa: Donor Blood Component Market - Revenue and Forecast Analysis - by End User
- 12.4.3 Middle East and Africa: Donor Blood Component Market - Revenue and Forecast Analysis - by Country
  - 12.4.3.1 Middle East and Africa: Donor Blood Component Market - Revenue and Forecast Analysis - by Country
  - 12.4.3.2 Saudi Arabia: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 12.4.3.2.1 Saudi Arabia: Donor Blood Component Market Breakdown, by Blood Component
    - 12.4.3.2.2 Saudi Arabia: Donor Blood Component Market Breakdown, by Blood Component
    - 12.4.3.2.3 Saudi Arabia: Donor Blood Component Market Breakdown, by Indication
      - 12.4.3.2.3.1 Saudi Arabia: Donor Blood Component Market Breakdown, by Immunosuppression
      - 12.4.3.2.3.2 Saudi Arabia: Donor Blood Component Market Breakdown, by Oncology
    - 12.4.3.2.4 Saudi Arabia: Donor Blood Component Market Breakdown, by Application
    - 12.4.3.2.5 Saudi Arabia: Donor Blood Component Market Breakdown, by Age Group
    - 12.4.3.2.6 Saudi Arabia: Donor Blood Component Market Breakdown, by End User
  - 12.4.3.3 South Africa: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 12.4.3.3.1 South Africa: Donor Blood Component Market Breakdown, by Blood Component
    - 12.4.3.3.2 South Africa: Donor Blood Component Market Breakdown, by Blood Component
    - 12.4.3.3.3 South Africa: Donor Blood Component Market Breakdown, by Indication
      - 12.4.3.3.3.1 South Africa: Donor Blood Component Market Breakdown, by Immunosuppression
      - 12.4.3.3.3.2 South Africa: Donor Blood Component Market Breakdown, by Oncology
    - 12.4.3.3.4 South Africa: Donor Blood Component Market Breakdown, by Application
    - 12.4.3.3.5 South Africa: Donor Blood Component Market Breakdown, by Age Group
    - 12.4.3.3.6 South Africa: Donor Blood Component Market Breakdown, by End User
  - 12.4.3.4 United Arab Emirates: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 12.4.3.4.1 United Arab Emirates: Donor Blood Component Market Breakdown, by Blood Component
    - 12.4.3.4.2 United Arab Emirates: Donor Blood Component Market Breakdown, by Blood Component
    - 12.4.3.4.3 United Arab Emirates: Donor Blood Component Market Breakdown, by Indication
      - 12.4.3.4.3.1 United Arab Emirates: Donor Blood Component Market Breakdown, by Immunosuppression
      - 12.4.3.4.3.2 United Arab Emirates: Donor Blood Component Market Breakdown, by Oncology
    - 12.4.3.4.4 United Arab Emirates: Donor Blood Component Market Breakdown, by Application
    - 12.4.3.4.5 United Arab Emirates: Donor Blood Component Market Breakdown, by Age Group
    - 12.4.3.4.6 United Arab Emirates: Donor Blood Component Market Breakdown, by End User
  - 12.4.3.5 Rest of Middle East and Africa: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 12.4.3.5.1 Rest of Middle East and Africa: Donor Blood Component Market Breakdown, by Blood Component
    - 12.4.3.5.2 Rest of Middle East and Africa: Donor Blood Component Market Breakdown, by Blood Component
    - 12.4.3.5.3 Rest of Middle East and Africa: Donor Blood Component Market Breakdown, by Indication
      - 12.4.3.5.3.1 Rest of Middle East and Africa: Donor Blood Component Market Breakdown, by Immunosuppression
      - 12.4.3.5.3.2 Rest of Middle East and Africa: Donor Blood Component Market Breakdown, by Oncology
    - 12.4.3.5.4 Rest of Middle East and Africa: Donor Blood Component Market Breakdown, by Application
    - 12.4.3.5.5 Rest of Middle East and Africa: Donor Blood Component Market Breakdown, by Age Group
    - 12.4.3.5.6 Rest of Middle East and Africa: Donor Blood Component Market Breakdown, by End User
12.5 South and Central America
- 12.5.1 South and Central America Donor Blood Component Market Overview
- 12.5.2 South and Central America: Donor Blood Component Market - Revenue, 2021-2031 (US$ Million)
  - 12.5.2.1 South and Central America: Donor Blood Component Market - Revenue and Forecast Analysis - by Blood Component
  - 12.5.2.2 South and Central America: Donor Blood Component Market - Volume and Forecast Analysis - by Blood Component
  - 12.5.2.3 South and Central America: Donor Blood Component Market - Revenue and Forecast Analysis - by Indication
    - 12.5.2.3.1 South and Central America: Donor Blood Component Market - Revenue and Forecast Analysis - by Immunosuppression
    - 12.5.2.3.2 South and Central America: Donor Blood Component Market - Revenue and Forecast Analysis - by Oncology
  - 12.5.2.4 South and Central America: Donor Blood Component Market - Revenue and Forecast Analysis - by Application
  - 12.5.2.5 South and Central America: Donor Blood Component Market - Revenue and Forecast Analysis - by Age Group
  - 12.5.2.6 South and Central America: Donor Blood Component Market - Revenue and Forecast Analysis - by End User
- 12.5.3 South and Central America: Donor Blood Component Market - Revenue and Forecast Analysis - by Country
  - 12.5.3.1 South and Central America: Donor Blood Component Market - Revenue and Forecast Analysis - by Country
  - 12.5.3.2 Brazil: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 12.5.3.2.1 Brazil: Donor Blood Component Market Breakdown, by Blood Component
    - 12.5.3.2.2 Brazil: Donor Blood Component Market Breakdown, by Blood Component
    - 12.5.3.2.3 Brazil: Donor Blood Component Market Breakdown, by Indication
      - 12.5.3.2.3.1 Brazil: Donor Blood Component Market Breakdown, by Immunosuppression
      - 12.5.3.2.3.2 Brazil: Donor Blood Component Market Breakdown, by Oncology
    - 12.5.3.2.4 Brazil: Donor Blood Component Market Breakdown, by Application
    - 12.5.3.2.5 Brazil: Donor Blood Component Market Breakdown, by Age Group
    - 12.5.3.2.6 Brazil: Donor Blood Component Market Breakdown, by End User
  - 12.5.3.3 Argentina: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 12.5.3.3.1 Argentina: Donor Blood Component Market Breakdown, by Blood Component
    - 12.5.3.3.2 Argentina: Donor Blood Component Market Breakdown, by Blood Component
    - 12.5.3.3.3 Argentina: Donor Blood Component Market Breakdown, by Indication
      - 12.5.3.3.3.1 Argentina: Donor Blood Component Market Breakdown, by Immunosuppression
      - 12.5.3.3.3.2 Argentina: Donor Blood Component Market Breakdown, by Oncology
    - 12.5.3.3.4 Argentina: Donor Blood Component Market Breakdown, by Application
    - 12.5.3.3.5 Argentina: Donor Blood Component Market Breakdown, by Age Group
    - 12.5.3.3.6 Argentina: Donor Blood Component Market Breakdown, by End User
  - 12.5.3.4 Rest of South and Central America: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 12.5.3.4.1 Rest of South and Central America: Donor Blood Component Market Breakdown, by Blood Component
    - 12.5.3.4.2 Rest of South and Central America: Donor Blood Component Market Breakdown, by Blood Component
    - 12.5.3.4.3 Rest of South and Central America: Donor Blood Component Market Breakdown, by Indication
      - 12.5.3.4.3.1 Rest of South and Central America: Donor Blood Component Market Breakdown, by Immunosuppression
      - 12.5.3.4.3.2 Rest of South and Central America: Donor Blood Component Market Breakdown, by Oncology
    - 12.5.3.4.4 Rest of South and Central America: Donor Blood Component Market Breakdown, by Application
    - 12.5.3.4.5 Rest of South and Central America: Donor Blood Component Market Breakdown, by Age Group
    - 12.5.3.4.6 Rest of South and Central America: Donor Blood Component Market Breakdown, by End User

13. Industry Landscape

13.1 Overview
13.2 Growth Strategies in the Donor Blood Component Market
13.3 Organic Growth Strategies
- 13.3.1 Overview
13.4 Inorganic Growth Strategies
- 13.4.1 Overview

14. COMPANY PROFILES

14.1 Roswell Park Comprehensive Cancer Center
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 Policlinico of Milan
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
14.3 Vitalant
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 MD Anderson Cancer Center.
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
14.5 The Johns Hopkins Hospital
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
14.6 The Royal Marsden
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
14.7 Gustave Roussy
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
14.8 Peter MacCallum Cancer Centre
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
14.9 Tata Memorial Hospital
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
14.10 Memorial Sloan Kettering Cancer Center
- 14.10.1 Key Facts
- 14.10.2 Business Description
- 14.10.3 Products and Services
- 14.10.4 Financial Overview
- 14.10.5 SWOT Analysis

15. Appendix

15.1 About The Insight Partners
15.2 Glossary of Terms